Vir is leveraging immunologic breakthroughs to address unmet patient needs in infectious disease and beyond. Backed by SoftBank VF.
About the role
Vir Bio is seeking an experienced Director, Clinical Operations to provide strategic and operational leadership for global oncology clinical trials. The individual will serve as a hands-on study leader responsible for the successful execution of complex clinical studies while contributing to broader program strategy, alliance management, operational excellence initiatives, and portfolio expansion efforts.
What they're looking for
- Bachelor's degree in Life Sciences or related field and 12+ years of clinical development experience within the biotechnology or pharmaceutical industry
- Significant experience leading complex global oncology clinical trials, with deep expertise in early-phase oncology development
- Demonstrated experience leading first-in-human and early-development oncology trials, including dose-escalation, backfill, expansion, signal-seeking, and dose-optimization studies
- Experience supporting development of novel oncology modalities, such as T-cell engagers, bispecific antibodies, immuno-oncology therapies, cell therapies, cytokine-based therapies, or related platforms
- Demonstrated expertise in global study start-up, site strategy, enrollment optimization, and recruitment planning across academic and community oncology networks
- Strong understanding of clinical trial design and execution, including operational considerations in oncology studies
More about this role
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN ® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.
Vir Biotechnology has exclusive rights to the universal PRO-XTEN ® masking platform for oncology and infectious disease. PRO-XTEN ® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.
Vir Bio is seeking an experienced Director, Clinical Operations to provide strategic and operational leadership for global oncology clinical trials. The individual will serve as a hands-on study leader responsible for the successful execution of complex clinical studies while contributing to broader...
Browse similar: Startup jobs · San Francisco Bay Area